should I be worried? before considering a reassessment with your healthcare provider if no benefits are felt
It may be reasonable to continue carnitine until the patient has improved clinically, valproate concentrations are at a therapeutic level, and ammonia levels have normalized
The following information was recorded for each ICSR
What Are GLP-1 Vision Loss Lawsuits About
Various microdosing protocols have been discussed in online patient communities and among some healthcare providers, though none have been formally studied or endorsed by regulatory authorities
A small clinical trial confirmed these findings, showing that exenatide, another GLP-1 agonist, significantly reduced intracranial pressure in patients with idiopathic intracranial hypertension, greatly improving headache symptoms